NAYA BIOSCIENCES INC.

0.9500

26-November-24 11:11:11

15 minutes delayed

Stocks

+0.0300

+3.26%

Today's range

0.9000 - 0.9607

ISIN

N/A

Source

NASDAQ

NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

31 Oct 2024 09:00:00 By Nasdaq GlobeNewswire
NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma

24 Oct 2024 09:00:00 By Nasdaq GlobeNewswire
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences

21 Oct 2024 09:00:00 By Nasdaq GlobeNewswire
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)

14 Oct 2024 09:18:20 By Nasdaq GlobeNewswire
INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA

14 Aug 2024 09:00:00 By Nasdaq GlobeNewswire
INVO Reports Record First Quarter 2024 Financial Results

15 May 2024 16:15:00 By Nasdaq GlobeNewswire
INVO Reports Fourth Quarter and Full Year 2023 Financial Results

16 Apr 2024 16:59:29 By Nasdaq GlobeNewswire

<<
<
1
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.